855-853-4760

customerservice@arevapharma.com

Capecitabine

Capecitabine

Capecitabine tablets are indicated as a single agent for adjuvant treatment in patients with Dukes’ C colon cancer who have undergone complete resection of the primary tumor when treatment with fluoropyrimidine therapy alone is preferred. Capecitabine tablets are noninferior to 5-fluorouracil and leucovorin (5-FU/LV) for disease-free survival (DFS). Physicians should consider results of combination chemotherapy trials, which have shown improvement in DFS and OS, when prescribing single-agent capecitabine tablets in the adjuvant treatment of Dukes’ C colon cancer.

Products Information

RX PRODUCTNDC#STRENGTHSIZEPRODUCT CLASSADMINISTRATIONCASE SIZE
Capecitabine
59923-722-12 500 mg 120Antineoplastic Oral N.A
WholesalerCapecitabine 500mg
AmerisourceBergen 10235955
Cardinal5680699
McKesson1573468